Pharmacologic activation of expression of immunodominant viral antigens: A new strategy for the treatment of Epstein-Barr-virus-associated malignancies

K. D. Robertson, J. Barletta, D. Samid, R. F. Ambinder

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Pharmacologic activation of expression of immunodominant viral antigens: A new strategy for the treatment of Epstein-Barr-virus-associated malignancies'. Together they form a unique fingerprint.